TrialAmerican heart journal2011

Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Zahi A Fayad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.